Experts discuss the humanistic and economic impacts that affect patients with inflammatory diseases. Ryan Haumschild, PharmD, MS, MBA: When we think about these diseases, we really need to focus on ...
Disease X, a term used for several years by the World Health Organization, refers to a hypothetical deadly pathogen that could lead to a global pandemic. World leaders and scientists have been ...
Attendees at the World Economic Forum in Davos will discuss the prospect of a virus far more potent than COVID being unleashed across the world. The hypothetical virus, dubbed by the World Health ...
Posters at ASN Kidney Week 2023 explored the economic burden brought on by chronic kidney disease (CKD) and further validated the Klinrisk model’s ability to predict progressive forms of CKD. Two ...
Please provide your email address to receive an email when new articles are posted on . The prevalence of many CVD conditions and risk factors is expected to increase greatly by 2050. Health care ...
As leaders gather for COP30, they must reject false narratives that pit climate and health action against economic growth.
WASHINGTON--(BUSINESS WIRE)--In one of the first studies of healthcare resource utilization and costs for patients with rare disease, the EveryLife Foundation for Rare Diseases reveals that timely ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Rebecca Vega Thurber, University of California, Santa Barbara (THE CONVERSATION) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results